BR112015011605A2 - quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas - Google Patents
quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadasInfo
- Publication number
- BR112015011605A2 BR112015011605A2 BR112015011605A BR112015011605A BR112015011605A2 BR 112015011605 A2 BR112015011605 A2 BR 112015011605A2 BR 112015011605 A BR112015011605 A BR 112015011605A BR 112015011605 A BR112015011605 A BR 112015011605A BR 112015011605 A2 BR112015011605 A2 BR 112015011605A2
- Authority
- BR
- Brazil
- Prior art keywords
- hydrazones
- quinolyl
- tuberculosis
- treatment
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT106651A PT106651A (pt) | 2012-11-20 | 2012-11-20 | Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas |
| PCT/PT2013/000069 WO2014081325A1 (en) | 2012-11-20 | 2013-11-20 | Quinolyl hydrazones for the treatment of tuberculosis and related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015011605A2 true BR112015011605A2 (pt) | 2017-07-11 |
Family
ID=49876953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015011605A BR112015011605A2 (pt) | 2012-11-20 | 2013-11-20 | quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9809550B2 (pt) |
| EP (1) | EP2934528B1 (pt) |
| BR (1) | BR112015011605A2 (pt) |
| CY (1) | CY1121690T1 (pt) |
| DK (1) | DK2934528T3 (pt) |
| ES (1) | ES2710124T3 (pt) |
| HR (1) | HRP20182198T1 (pt) |
| HU (1) | HUE043021T2 (pt) |
| LT (1) | LT2934528T (pt) |
| MA (1) | MA38207B1 (pt) |
| PL (1) | PL2934528T3 (pt) |
| PT (2) | PT106651A (pt) |
| RS (1) | RS58185B1 (pt) |
| SI (1) | SI2934528T1 (pt) |
| TR (1) | TR201900156T4 (pt) |
| WO (1) | WO2014081325A1 (pt) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080118576A1 (en) * | 2006-08-28 | 2008-05-22 | Dan Theodorescu | Prediction of an agent's or agents' activity across different cells and tissue types |
| EP2367820B1 (en) * | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Novel antimicrobial agents |
| EP2287149A1 (en) * | 2009-08-20 | 2011-02-23 | Max-Delbrück-Centrum Für Molekulare Medizin | Enhancers of protein degradation |
| EP2311457A1 (en) | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| US8779153B2 (en) * | 2010-10-13 | 2014-07-15 | Glaxo Group Limited | 3-amino-pyrazole derivatives useful against tuberculosis |
-
2012
- 2012-11-20 PT PT106651A patent/PT106651A/pt unknown
-
2013
- 2013-11-20 SI SI201331305T patent/SI2934528T1/sl unknown
- 2013-11-20 MA MA38207A patent/MA38207B1/fr unknown
- 2013-11-20 PL PL13811633T patent/PL2934528T3/pl unknown
- 2013-11-20 DK DK13811633.0T patent/DK2934528T3/en active
- 2013-11-20 PT PT13811633T patent/PT2934528T/pt unknown
- 2013-11-20 US US14/443,787 patent/US9809550B2/en active Active
- 2013-11-20 BR BR112015011605A patent/BR112015011605A2/pt not_active Application Discontinuation
- 2013-11-20 RS RS20181598A patent/RS58185B1/sr unknown
- 2013-11-20 WO PCT/PT2013/000069 patent/WO2014081325A1/en active Application Filing
- 2013-11-20 HU HUE13811633A patent/HUE043021T2/hu unknown
- 2013-11-20 EP EP13811633.0A patent/EP2934528B1/en active Active
- 2013-11-20 ES ES13811633T patent/ES2710124T3/es active Active
- 2013-11-20 LT LTEP13811633.0T patent/LT2934528T/lt unknown
- 2013-11-20 TR TR2019/00156T patent/TR201900156T4/tr unknown
-
2018
- 2018-12-31 HR HRP20182198TT patent/HRP20182198T1/hr unknown
-
2019
- 2019-01-09 CY CY20191100018T patent/CY1121690T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA38207A2 (fr) | 2016-12-30 |
| DK2934528T3 (en) | 2019-02-04 |
| HRP20182198T1 (hr) | 2019-02-22 |
| EP2934528A1 (en) | 2015-10-28 |
| ES2710124T3 (es) | 2019-04-23 |
| HUE043021T2 (hu) | 2019-08-28 |
| WO2014081325A1 (en) | 2014-05-30 |
| US9809550B2 (en) | 2017-11-07 |
| LT2934528T (lt) | 2019-02-11 |
| TR201900156T4 (tr) | 2019-02-21 |
| EP2934528B1 (en) | 2018-11-07 |
| PT2934528T (pt) | 2019-03-20 |
| US20150299128A1 (en) | 2015-10-22 |
| MA38207B1 (fr) | 2018-06-29 |
| PL2934528T3 (pl) | 2019-05-31 |
| CY1121690T1 (el) | 2020-07-31 |
| RS58185B1 (sr) | 2019-03-29 |
| PT106651A (pt) | 2014-05-20 |
| SI2934528T1 (sl) | 2019-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1217439A1 (zh) | 與毒性醛相關的疾病和治療 | |
| BR112015002524A2 (pt) | derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças. | |
| BR112016026378A2 (pt) | formulações e métodos para tratamento com queratina | |
| ZA201506984B (en) | Microarray for delivery of therapeutic agent and methods of use | |
| BR112015023124A2 (pt) | liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal | |
| BR112013018469A2 (pt) | dispositivos e métodos para tratamento de tecidos | |
| BR112014009634A2 (pt) | preparação e agente terapêutico | |
| DK2877184T3 (da) | Sammensætninger og behandling for øjensygdomme og -lidelser | |
| BR112015001712A2 (pt) | uso de s-pindolol para o tratamento da caquexia e sarcopenia | |
| DK2882441T3 (da) | Behandling af immunrelaterede og inflammatoriske sygdomme | |
| BR112014016937A2 (pt) | terapia de combinação para o tratamento de desordens de audição e do equilíbrio | |
| BR112014022694A2 (pt) | novos métodos e composições para o tratamento de doença | |
| BR112014031512A2 (pt) | composição cosmética e método para o tratamento cosmético. | |
| BR112014004416A2 (pt) | composições e métodos para o tratamento de doenças neurodegenerativas | |
| DK2688588T3 (da) | Hurtig- og langtidsvirkende immunologisk terapeutisk middel | |
| BR112015010428A2 (pt) | agente terapêutico para distúrbios ceratoconjuntivos | |
| BR112014010560A2 (pt) | drogas para inibir p38 e usos das mesmas | |
| BR112014009421A2 (pt) | combinação terapêutica e método para tratamento | |
| HRP20182198T1 (hr) | Kinolil hidrazona za liječenje tuberkuloze i srodnih bolesti | |
| BR112015011606A2 (pt) | piridil hidrazonas para o tratamento de tuberculose e doenças relacionadas | |
| ES1087856Y (es) | Aposento para tratamiento terapeutico de animales | |
| ES1077585Y (es) | Dispositivo para masaje cardiaco y/o activacion cardiorrespiratoria | |
| ES1078976Y (es) | Fibroscopio para masaje cardiaco y/o activacion cardiorespiratoria | |
| ES1075969Y (es) | Ortesis para animales y personas | |
| ES1075235Y (es) | Dispositivo para la estimulacion fisica y cognitiva de pacientes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |